Why does intensive insulin therapy implemented at the onset of type 1 diabetes not decrease prevalence of diabetic microangiopathy?

Journal Title: Archives of Medical Science - Year 2008, Vol 4, Issue 2

Abstract

Authors and Affiliations

Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Magdalena Trepińska, Bogna Wierusz-Wysocka

Keywords

Related Articles

Rhabdomyolysis following severe hypokalemia caused by Conn’s syndrome

Rhabdomyolysis denotes a clinical and laboratory syndrome that results from a rapid breakdown of skeletal muscle cells. This releases potentially toxic muscle cell components into the circulation which may cause life-t...

Effects of absorbed dose of 131I isotope on the effectiveness of ablation of thyroid remnant tissue

Introduction: The aim of the study was the assesment of effective ablative dose of absorbed 131I radiation, based on dosimetric measurements. Material and methods: The study group comprised one hundred (100) patients in...

How to plan an experiment I. Randomization: current fad or (ever)lasting fashion?

All those who like experimentation are sooner or later faced with a need of random selection of elements or objects of interest that they want to study (persons, patients, animals, cells, etc.). Randomization, a basic re...

Download PDF file
  • EP ID EP96708
  • DOI -
  • Views 168
  • Downloads 0

How To Cite

Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Magdalena Trepińska, Bogna Wierusz-Wysocka (2008). Why does intensive insulin therapy implemented at the onset of type 1 diabetes not decrease prevalence of diabetic microangiopathy?. Archives of Medical Science, 4(2), 167-173. https://europub.co.uk./articles/-A-96708